Zevra Therapeutics, Inc. (ZVRA) stock
ZVRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3060% below fair value
$9.28−0.12 (-1.28%)
Close on Nov 18, 2026Market cap $551.08MP/E 10.0Yield –
Zevra Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Zevra Therapeutics's market cap was $703.20M on Nov 11, 2026, against $473.92M a year earlier. Over the last 5 years it ranged from $152.00M to $847.71M, with a median of $279.94M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $703.20M | +39.6% |
| 2025 | Dec 31, 2025 | $503.71M | +13.5% |
| 2024 | Dec 31, 2024 | $443.92M | +87.2% |
| 2023 | Dec 29, 2023 | $237.19M | +49.8% |
| 2022 | Dec 30, 2022 | $158.36M | -48.5% |
| 2021 | Dec 31, 2021 | $307.61M | +506.0% |
| 2020 | Dec 31, 2020 | $50.76M | +313.2% |
| 2019 | Dec 31, 2019 | $12.28M | -57.0% |
| 2018 | Dec 31, 2018 | $28.55M | -51.9% |
| 2017 | Dec 29, 2017 | $59.36M | +37.4% |
| 2016 | Dec 30, 2016 | $43.21M | -84.7% |
| 2015 | Dec 31, 2015 | $282.84M | – |
See a number that looks wrong?